.jpg "Eileen M. O'Reilly, MD photo")
Memorial Sloan Kettering Cancer Center
New York, United States
Dr. Eileen M. O’Reilly serves as Section Head for Hepatopancreaticobiliary /Neuroendocrine Cancers, Gastrointestinal Oncology Service, Co-Director Medical for the David M. Rubenstein Center for Pancreatic Cancer at Memorial Sloan Kettering (MSK) and is an Attending Physician and Member at MSK and Professor of Medicine at Weill Cornell Medical College. Dr. O’Reilly holds the Winthrop Rockefeller Endowed Chair in Medical Oncology.
Dr. O’Reilly received her medical degree at Trinity College (Dublin University) in Ireland. She completed her residency training in Ireland and Fellowship training at MSK. Dr. O’Reilly has pancreatic and hepatobiliary malignancies as the major focus of her research and clinical activities. Research directions include integration of molecular and genetic-based therapies for the treatment of pancreas cancer along with development of adjuvant and neoadjuvant therapies and identification of biomarkers for therapy selection. Dr. O’Reilly teaches and mentors oncology fellows, junior faculty, residents and medical/other students and has numerous teaching and other awards. Dr. O’Reilly is the Principal Investigator of multiple trials in pancreas cancer and has authored/co-authored > 330 articles, editorials and book chapters.
Dr. O’Reilly’s other responsibilities include: Chair of MSK’s Human Research Protection Program/ IRB, Chair of the Continuing Medical Education (CME) committee. Nationally Dr. O’Reilly is Co-Chair of the NCI Alliance Co-Operative Group Gastrointestinal Cancers Committee and serves on the Medical and Scientific Advisory Board of the Pancreatic Cancer Action Network and PanKIND, ASCO Guidelines Committee and the Board of the National Pancreas Foundation. Dr. O'Reilly also serves as Associate/Senior Editor for several oncology journals
Wednesday, June 29, 2022
15:55 – 16:15
Wednesday, June 29, 2022
16:15 – 17:00